InvestorsHub Logo
Followers 116
Posts 1878
Boards Moderated 0
Alias Born 11/22/2017

Re: learningcurve2020 post# 311539

Saturday, 09/26/2020 7:58:40 PM

Saturday, September 26, 2020 7:58:40 PM

Post# of 704484

I don’t even see NWBO mentioned with LL. Only Bosch. Troubling.



learningcurve2020,

Wrong!

Late-Breaking
Clinical trials: Immunologic
Plenary I
LTBK-02 - Phase III Clinical Trial to Test the Safety and Efficacy of Autologous Tumor Lysate-Loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma
Friday, November 20, 2020

Live Abstract Presenter(s)

Linda Liau, MD, PhD

Director, Brain Tumor Program, UCLA David Geffen School of Medicine
University of California Los Angeles
Arbor Pharmaceuticals (Consultant)JW Creagene (Consultant)

This trial is registered with clinicaltrials.gov, number NCT00045968.



clinicaltrials.gov, number NCT00045968

Sponsor:
Northwest Biotherapeutics
Information provided by (Responsible Party):
Northwest Biotherapeutics


https://clinicaltrials.gov/ct2/show/NCT00045968


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News